Anti-Human MUC6 Monoclonal Antibody (1A591)

Introduction

The Anti-Human MUC6 Monoclonal Antibody (1A591) is a highly specific antibody that targets the MUC6 protein, which is a member of the mucin family of glycoproteins. MUC6 is primarily expressed in the gastrointestinal tract and has been found to play a role in protecting the mucosal lining of the stomach from damage caused by stomach acid and other irritants. This antibody has been extensively studied and has shown promising results in various research areas, making it a valuable tool for scientists.

Structure of Anti-Human MUC6 Monoclonal Antibody (1A591)

The Anti-Human MUC6 Monoclonal Antibody (1A591) is a monoclonal antibody, meaning it is produced by a single clone of B cells and is therefore highly specific and consistent in its binding to the target protein. It is a type of immunoglobulin G (IgG) antibody and has a molecular weight of approximately 150 kDa. The antibody is composed of two heavy chains and two light chains, each with a variable region that specifically binds to the MUC6 protein.
The crystal structure of Anti-Human MUC6 Monoclonal Antibody (1A591) has been determined through X-ray crystallography, revealing the specific binding sites on the antibody that interact with the MUC6 protein. This information has helped in understanding the mechanism of action of the antibody and has aided in the development of more effective versions of the antibody.

Activity of Anti-Human MUC6 Monoclonal Antibody (1A591)

The main activity of Anti-Human MUC6 Monoclonal Antibody (1A591) is its ability to specifically bind to the MUC6 protein and inhibit its function. This is achieved through the binding of the antibody to the extracellular domain of the MUC6 protein, which prevents it from interacting with other molecules and carrying out its normal functions.
Studies have shown that this antibody can effectively block the binding of MUC6 to its receptor, resulting in decreased cell proliferation and increased cell death in cancer cells that overexpress MUC6. This makes it a potential therapeutic agent for the treatment of MUC6-expressing cancers, such as gastric and pancreatic cancer.
In addition to its inhibitory activity, Anti-Human MUC6 Monoclonal Antibody (1A591) has also been used as a detection tool in various research studies. Its high specificity and sensitivity make it a valuable tool for detecting the presence and expression levels of MUC6 in different tissues and cell lines.

Applications of Anti-Human MUC6 Monoclonal Antibody (1A591)

The high specificity and activity of Anti-Human MUC6 Monoclonal Antibody (1A591) make it a versatile tool for various research applications. Some of its main applications include:

• Cancer research: The overexpression of MUC6 has been linked to the development and progression of various cancers, making it a potential target for cancer therapy. Anti-Human MUC6 Monoclonal Antibody (1A591) has been used in numerous studies to investigate the role of MUC6 in cancer and to develop targeted therapies.
• Diagnostic tool: The expression of MUC6 has been found to be altered in various diseases, including gastric and pancreatic cancer. The use of Anti-Human MUC6 Monoclonal Antibody (1A591) as a diagnostic tool can aid in the early detection and diagnosis of these diseases.
• Drug development: The specific binding and inhibitory activity of Anti-Human MUC6 Monoclonal Antibody (1A591) make it a potential candidate for the development of novel therapeutics targeting MUC6. Its use in drug screening assays can aid in the